Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT02842333. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies
ClinicalTrials.gov study NCT00840190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04111705. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT03610971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tyrosine Kinase 2 (TYK2) for GA and CS
ClinicalTrials.gov study NCT06725264. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers
ClinicalTrials.gov study NCT02552953. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)
ClinicalTrials.gov study NCT02342353. IPD Sharing: NO. Countries: 1. Publications: 0.
Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea
ClinicalTrials.gov study NCT05616923. IPD Sharing: NO. Countries: 1. Publications: 0.
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
ClinicalTrials.gov study NCT05845671. IPD Sharing: NO. Countries: 1. Publications: 0.
Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT05670054. IPD Sharing: YES. Countries: 1. Publications: 0.
Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency
ClinicalTrials.gov study NCT06497829. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors
ClinicalTrials.gov study NCT03571438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Protein Kinase 2 (HIPK2) Polymorphisms on rs2058265, rs6464214, and rs7456421
ClinicalTrials.gov study NCT04804436. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhib
ClinicalTrials.gov study NCT05555979. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas
ClinicalTrials.gov study NCT02055924. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03817398. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model
ClinicalTrials.gov study NCT05136014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy
ClinicalTrials.gov study NCT00074854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of PAthways of Kinase Inhibitors TOxicity
ClinicalTrials.gov study NCT03896139. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes
ClinicalTrials.gov study NCT06712680. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.